Clinical research

Outcomes in patients undergoing multivessel percutaneous coronary intervention using sirolimus-eluting stents: a report from the e-SELECT registry

EuroIntervention 2011;7:962-968. DOI: 10.4244/EIJV7I8A152

Florim Cuculi
Florim Cuculi1, MD; Adrian P. Banning1*, MD; Alexander Abizaid2, MD, FACC; Antonio L. Bartorelli3, MD, FACC; Ana C. Baux4, PhD; Vladimir Džavík5, MD, FACC; Stepehen Ellis6, MD, FACC; Runlin Gao7, MD, FACC; David Holmes8, MD, FACC; Myung H. Jeong9, MD, FACC; Victor Legrand10, MD; Franz-Josef Neumann11, MD; Maria Nyakern4, PhD; Christian Spaulding12, MD, FACC; Hans-Peter Stoll4, MD; Stephen Worthley13, MD, FACC; Philip Urban14, MD, FACC; e-SELECT investigators
1. Oxford Heart Centre, Oxford, United Kingdom; 2. Instituto Dante Pazzanese de Cardiologia, Sao Paolo, Brazil; 3. Centro Cardiologico Monzino, IRCCS, University of Milan, Milan, Italy; 4. Cordis Clinical Research Europe, Waterloo, Belg

Aims: Performing percutaneous coronary intervention (PCI) to multiple coronary lesions during the same procedure has potential economic and social advantages. However com

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

clinical researchsirolimus-eluting stentcoronary artery diseasecomplex lesions
Read next article
Three-year clinical event rates in different age groups after contemporary percutaneous coronary intervention

Latest news